fullerene c60 has been researched along with sulforaphane in 1 studies
| Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (sulforaphane) | Trials (sulforaphane) | Recent Studies (post-2010) (sulforaphane) |
|---|---|---|---|---|---|
| 3,806 | 5 | 2,170 | 1,754 | 65 | 1,317 |
| Protein | Taxonomy | fullerene c60 (IC50) | sulforaphane (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 9 | |
| Macrophage migration inhibitory factor | Homo sapiens (human) | 2.2 | |
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | 0.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, T; Lin, Y; Tian, F; Whitman, SA; Zhang, DD; Zhang, N; Zhang, Z; Zheng, H | 1 |
1 other study(ies) available for fullerene c60 and sulforaphane
| Article | Year |
|---|---|
Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response.
Topics: Adult; Animals; Antibodies, Monoclonal; Case-Control Studies; Cells, Cultured; Disease Models, Animal; DNA Damage; Female; Fibronectins; Fullerenes; Humans; Inflammation Mediators; Isothiocyanates; Kidney Glomerulus; Lupus Nephritis; Male; Mice; Mice, Knockout; Middle Aged; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; Reactive Oxygen Species; RNA Interference; Severity of Illness Index; Signal Transduction; Sulfoxides; Transfection; Transforming Growth Factor beta1 | 2014 |